Developer docs
API playgroundTry for free, no card

Search company profiles

Maverick Ventures

Full company profile

uuid000031x

Namestring
Maverick Ventures
Legal namestring
Maverick Capital
Company typeenum
Private
Founded yearint
1993
Descriptiontext

Maverick Ventures is the venture capital arm of Maverick Capital, a private investment management firm founded in 1993 and headquartered in Stamford, Connecticut, with the venture group operating out of San Francisco. The firm invests in early-stage healthcare and technology-driven businesses, leading and co-leading Seed through Series B rounds and partnering with a select group of founders each year. It positions itself as part of a multi-stage platform that collaborates across private and public strategies, supporting portfolio companies from inception through IPO and beyond, and offering quant and data resources, deep AI networks, and strategic LP relationships as differentiated support.

The firm manages over $1.4 billion in early-stage assets following the close of its $240 million fourth fund in 2025, with 30% of capital committed by Maverick partners and employees as the largest single LP. Revenue is generated through conventional VC economics — management fees on committed capital and carried interest on realizations — rather than product sales. The investment team is led by founder Lee Ainslie, alongside managing partner David Singer, managing directors Ambar Bhattacharyya, Ryan Isono, and Prateesh Maheshwari, principal Lexi Henkel, CFO Suzanne Guthrie, and COO Katherine Gomer.

Maverick Ventures' portfolio spans AI-native healthcare (Chapter, Nourish, Daffodil Health, Claim Health, Daymark Health, Cityblock, Devoted Health, Hims & Hers, One Medical), AI-driven enterprise software (BlueFlag Security, Cambio, Casium), and prior high-profile outcomes including BioCatch (acquired by Permira), MosaicML (acquired by Databricks), io (acquired by OpenAI), Coupang (IPO), and One Medical (IPO/acquired by Amazon). The firm does not offer products or services for sale, has no disclosed app or API surface, and competes on capital, network, and platform continuity rather than technology licensing.

Short descriptiontext

Maverick Ventures is the venture capital arm of Maverick Capital, leading Seed through Series B rounds in early-stage healthcare and technology companies. It manages over $1.4 billion in early-stage AUM and supports founders from inception through IPO.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
early-stage venture capital, seed stage investing, healthcare technology investments, technology venture capital, private equity investments
Industry1 code
1Early-Stage Venture Capital (Series A/B)
CodeFSANAAABPrimaryYes
NAICS code2 codes
  • Portfolio Management and Investment Advice52394
  • Other Investment Pools and Funds5259
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
Social media profiles1 record
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Maverick Ventures is the venture capital arm of Maverick Capital that leads Seed through Series B rounds in early-stage healthcare and technology-driven businesses. The firm partners with a select group of founders each year, providing capital, strategic resources, and long-term support from inception through IPO and beyond as part of a multi-stage platform combining private and public investment strategies.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Maverick Ventures Early-Stage Venture Capital Fund
CategoryVenture Capital Fund
Description

Early-stage venture capital fund that leads Seed through Series B rounds in healthcare and technology-driven businesses, providing capital, strategic resources, and long-term support from inception through IPO and beyond. Available to institutional and strategic limited partners as a commingled fund vehicle.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Multi-stage venture firm with a strong healthcare focus and a "creation" model that builds companies from inception — directly comparable to Maverick Ventures' early-stage healthcare and AI thesis and multi-stage platform approach.

TypeDirect peer
Description

One of the largest early-stage venture firms with dedicated bio/health and AI verticals and significant AUM — directly comparable in stage focus, sector mix, and ability to lead Seed through Series B rounds.

TypeDirect peer
Description

Early-stage VC with a high-conviction healthcare and deep-tech orientation and willingness to lead seed rounds — closely comparable to Maverick Ventures' thesis-driven, founder-led approach.

TypeDirect peer
Description

Early-stage-focused venture firm that leads concentrated seed and Series A rounds in ambitious technology companies — comparable to Maverick Ventures in stage, check size, and conviction-driven model.

TypeDirect peer
Description

Multi-stage VC with significant early-stage activity across enterprise and consumer technology — comparable to Maverick Ventures' breadth across seed-to-growth stages and similar fund size.

TypeDirect peer
Description

Large early-stage venture firm investing across healthcare, AI, and enterprise technology with a similar Seed-to-Series B lead posture to Maverick Ventures.

TypeDirect peer
Description

Early-stage venture arm of a large alternative asset manager — structurally analogous to Maverick Ventures as the venture arm of a broader investment platform (Maverick Capital), with similar AUM scale and stage focus.

TypeDirect peer
Description

Early-stage VC with deep-tech and healthcare concentration and a high-conviction, concentrated-portfolio approach — comparable to Maverick Ventures' thesis style and sector mix.

TypeBroad incumbent
Description

One of the most established multi-stage venture firms with broader sector coverage and larger AUM — broader incumbent that operates in the same Seed-through-IPO stages as Maverick Ventures but at substantially greater scale.

TypeDirect peer
Description

Specialized early-stage healthcare venture firm that frequently co-invests with Maverick Ventures (e.g., Daffodil Health Series A) — directly comparable in stage, healthcare focus, and check size.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment241 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Maverick Ventures

Venture Capitalmaverickventures.com

Maverick Ventures is the venture capital arm of Maverick Capital, leading Seed through Series B rounds in early-stage healthcare and technology companies. It manages over $1.4 billion in early-stage AUM and supports founders from inception through IPO.

What Maverick Ventures does

Maverick Ventures is the venture capital arm of Maverick Capital, a private investment management firm founded in 1993 and headquartered in Stamford, Connecticut, with the venture group operating out of San Francisco. The firm invests in early-stage healthcare and technology-driven businesses, leading and co-leading Seed through Series B rounds and partnering with a select group of founders each year. It positions itself as part of a multi-stage platform that collaborates across private and public strategies, supporting portfolio companies from inception through IPO and beyond, and offering quant and data resources, deep AI networks, and strategic LP relationships as differentiated support.

The firm manages over $1.4 billion in early-stage assets following the close of its $240 million fourth fund in 2025, with 30% of capital committed by Maverick partners and employees as the largest single LP. Revenue is generated through conventional VC economics — management fees on committed capital and carried interest on realizations — rather than product sales. The investment team is led by founder Lee Ainslie, alongside managing partner David Singer, managing directors Ambar Bhattacharyya, Ryan Isono, and Prateesh Maheshwari, principal Lexi Henkel, CFO Suzanne Guthrie, and COO Katherine Gomer.

Maverick Ventures' portfolio spans AI-native healthcare (Chapter, Nourish, Daffodil Health, Claim Health, Daymark Health, Cityblock, Devoted Health, Hims & Hers, One Medical), AI-driven enterprise software (BlueFlag Security, Cambio, Casium), and prior high-profile outcomes including BioCatch (acquired by Permira), MosaicML (acquired by Databricks), io (acquired by OpenAI), Coupang (IPO), and One Medical (IPO/acquired by Amazon). The firm does not offer products or services for sale, has no disclosed app or API surface, and competes on capital, network, and platform continuity rather than technology licensing.

Maverick Ventures firmographics

Firmographics
Name
Maverick Ventures
Legal name
Maverick Capital
Website
https://maverickventures.com
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
11–50 employees
Short description
Maverick Ventures is the venture capital arm of Maverick Capital, leading Seed through Series B rounds in early-stage healthcare and technology companies. It manages over $1.4 billion in early-stage AUM and supports founders from inception through IPO.
Ownership category
akta.pro rank

Maverick Ventures industry classification

Industry
Product category
Venture Capital
NAICS
Portfolio Management and Investment Advice (52394), Other Investment Pools and Funds (5259)
SIC
Investment Advice (6282)
akta.pro primary industry
Early-Stage Venture Capital (Series A/B) (FSANAAAB)

Keywords

  • Early-stage venture capital
  • Seed stage investing
  • Healthcare technology investments
  • Technology venture capital
  • Private equity investments

Where Maverick Ventures is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Markets served

Maverick Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Marketing channels3 records

Maverick Ventures product offering

Product offering

Core offering

Maverick Ventures is the venture capital arm of Maverick Capital that leads Seed through Series B rounds in early-stage healthcare and technology-driven businesses. The firm partners with a select group of founders each year, providing capital, strategic resources, and long-term support from inception through IPO and beyond as part of a multi-stage platform combining private and public investment strategies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Maverick Ventures Early-Stage Venture Capital Fund Early-stage venture capital fund that leads Seed through Series B rounds in healthcare and technology-driven businesses, providing capital, strategic resources, and long-term support from inception through IPO and beyond. Available to institutional and strategic limited partners as a commingled fund vehicle.

Companies that use Maverick Ventures

Customer profile

Ideal customer profiles2 records

Maverick Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Maverick Ventures partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Maverick Ventures competitors and assessment

Company assessment

Direct peers

  • General Catalyst: Multi-stage venture firm with a strong healthcare focus and a "creation" model that builds companies from inception — directly comparable to Maverick Ventures' early-stage healthcare and AI thesis and multi-stage platform approach.
  • Andreessen Horowitz (a16z): One of the largest early-stage venture firms with dedicated bio/health and AI verticals and significant AUM — directly comparable in stage focus, sector mix, and ability to lead Seed through Series B rounds.
  • Khosla Ventures: Early-stage VC with a high-conviction healthcare and deep-tech orientation and willingness to lead seed rounds — closely comparable to Maverick Ventures' thesis-driven, founder-led approach.
  • Founders Fund: Early-stage-focused venture firm that leads concentrated seed and Series A rounds in ambitious technology companies — comparable to Maverick Ventures in stage, check size, and conviction-driven model.
  • Lightspeed Venture Partners: Multi-stage VC with significant early-stage activity across enterprise and consumer technology — comparable to Maverick Ventures' breadth across seed-to-growth stages and similar fund size.
  • GV (Google Ventures): Large early-stage venture firm investing across healthcare, AI, and enterprise technology with a similar Seed-to-Series B lead posture to Maverick Ventures.
  • Bain Capital Ventures: Early-stage venture arm of a large alternative asset manager — structurally analogous to Maverick Ventures as the venture arm of a broader investment platform (Maverick Capital), with similar AUM scale and stage focus.
  • Lux Capital: Early-stage VC with deep-tech and healthcare concentration and a high-conviction, concentrated-portfolio approach — comparable to Maverick Ventures' thesis style and sector mix.
  • Flare Capital Partners: Specialized early-stage healthcare venture firm that frequently co-invests with Maverick Ventures (e.g., Daffodil Health Series A) — directly comparable in stage, healthcare focus, and check size.

Broad incumbents

  • Sequoia Capital: One of the most established multi-stage venture firms with broader sector coverage and larger AUM — broader incumbent that operates in the same Seed-through-IPO stages as Maverick Ventures but at substantially greater scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Maverick Ventures social profiles

Digital presence

Maverick Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Maverick Ventures leadership team

Management profile

Number of profiles

Profiles8 records

Maverick Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Maverick Ventures M&A and investment

M&A and investment

M&A

Investments241 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Maverick Ventures

What does Maverick Ventures do?

Maverick Ventures is the venture capital arm of Maverick Capital that leads Seed through Series B rounds in early-stage healthcare and technology-driven businesses. The firm partners with a select group of founders each year, providing capital, strategic resources, and long-term support from inception through IPO and beyond as part of a multi-stage platform combining private and public investment strategies.

Is Maverick Ventures a public or private company?

Maverick Ventures is a private company. It is classified as corporate owned and is currently operating.

When was Maverick Ventures founded?

Maverick Ventures was founded in 1993. It employs 11 to 50 people.

Where is Maverick Ventures based?

Maverick Ventures is headquartered in San Francisco, United States, in the North America region.

Who are Maverick Ventures's main competitors?

Direct peers on record are General Catalyst, Andreessen Horowitz (a16z), Khosla Ventures, Founders Fund, Lightspeed Venture Partners, GV (Google Ventures), Bain Capital Ventures, Lux Capital and Flare Capital Partners. Sequoia Capital is listed as a broad incumbent.

Does Maverick Ventures have an API?

No public API is recorded for Maverick Ventures.

What industry is Maverick Ventures in?

Maverick Ventures's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B). Its NAICS code is 52394 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Tech Funding NewsMenlo Ventures leads $100M round in Nourish to give every GLP-1 patient a dietitian as weight loss drugs take off — TFNNourish raised $100M in a Series C round led by Menlo Ventures, valuing the metabolic health startup at $1.75 billion. The company, which pairs dietitians with AI care agents, now serves over 10,000 dietitians across all 50 US states. The funding will expand its clinical network and deepen insurer partnerships.Venture Capital Access OnlineNourish Raises $100M Series C to Reverse Chronic Disease with AI-Native Metabolic ClinicNourish raised $100 million in a Series C led by Menlo Ventures, bringing total funding to $215 million. The funds will expand its AI-native metabolic clinic, which reports 8% weight loss and 1.3 point A1C reduction. The company plans to deepen partnerships with health plans and employers.MedCity NewsNourish Secures $100M for Metabolic Health ClinicNourish, a metabolic health clinic, raised $100 million in Series C funding led by Menlo Ventures. The New York City-based company has over 10,000 registered dietitians and has raised $215 million total. The funds will expand its clinical network and invest in AI agents.The SaaS NewsChapter Raises $100 Million Series EChapter, a New York-based AI retirement company, raised $100 million in Series E funding led by Generation Investment Management. The capital will accelerate growth and expand its product suite beyond Medicare into broader retirement and financial decision-making services.MedCity NewsWith $100M Raise, Chapter Targets Medicare Mismatches for SeniorsChapter, a Medicare navigation platform, raised $100 million in Series E funding led by Generation Investment Management. The New York-based company's valuation reached $3 billion, and it claims seniors face $100 billion in deadweight loss annually from coverage mismatches. The company plans to expand beyond Medicare with new products.FinSMEsChapter Raises $100M in Series E FundingChapter, a Medicare navigation platform, raised $100M in Series E funding led by Generation Investment Management. The company grew revenue 3x in 2025 and surpassed $100M ARR, and will use the funds to accelerate growth and launch additional financial products.The SaaS NewsCambio Raises $18 Million in Series ACambio, an AI-native commercial real estate operations platform headquartered in San Francisco, has raised $18 million in Series A funding led by Maverick Ventures, with participation from Y Combinator, Adverb Ventures, Peterson Ventures, and angel investors. The company will use the funding to scale its agentic AI platform globally and expand into U.S., EU, UK, and APAC markets, having already launched in over 35 countries with customers including Principal Real Estate, Nuveen Real Estate, and BGO. Founded by Leia de Guzman and Stephanie Grayson, Cambio uses AI to help real estate investors evaluate and prioritize retrofit opportunities across thousands of buildings simultaneously.ClaimhealthAnnouncing our $4.4m Seed RoundClaim Health announced the closing of a $4.4 million seed round led by Maverick Ventures, with participation from Peak XV, Y Combinator, and DHVP, to accelerate development of AI-powered revenue cycle infrastructure for home-based care providers. The funding will support product expansion of AI capabilities, hiring engineers and operators, and scaling customer success operations. The company aims to address revenue leakage in post-acute care by preventing issues at intake before they become costly denials 30 days later.PR NewswireSpear Bio, developer of the next-generation ultrasensitive immunodiagnostics and proteomics platform, completes raise of tens of millions of US dollars with oversubscribed Seed PrimeSpear Bio Inc. completed a tens of millions of dollars Seed Prime funding round led by CDH Investments, with participation from Maverick Ventures and YongHua Capital. The company is developing the SPEAR platform, an ultrasensitive immunodiagnostics technology that offers higher sensitivity than current digital immunoassay platforms without requiring expensive proprietary readers. This funding supports Spear Bio's efforts to commercialize assays for neurology, immunology, and oncology following the successful validation of its SARS-CoV-2 antibody test.Venture Capital Access OnlineCareHarmony Secures $15 million in Series A Funding Led by Maverick VenturesCareHarmony has closed a $15 million Series A funding round led by Maverick Ventures, with participation from Nashville Capital Network. The capital will be used to develop its proprietary CareBlocks™ technology and accelerate hiring to meet growing demand for care coordination solutions in value-based healthcare. This investment follows the company's reported success in helping clients achieve shared savings in 95% of Medicare Shared Savings Program instances over the past four years.